论文部分内容阅读
肌层浸润性膀胱癌的发病率随人群年龄的增长而增高。随着人群预期寿命的延长,肌层浸润性膀胱癌老年患者的数量愈发增多。现有的关于肌层浸润性膀胱癌的诊疗指南并未排除该病老年患者的根治疗法。然而,任何一种治疗方式都有必要对其风险及获益进行评估,以避免过度治疗,因过度治疗非但不能延长患者的生存期,还造成与健康相关的生活质量的下降。我们对年龄大于70岁的肌层浸润性膀胱癌
The incidence of myometrial invasive bladder cancer increases with the age of the population. With the extension of life expectancy, the number of elderly patients with myometrial invasive bladder cancer is increasing. The current guidelines for the diagnosis and treatment of myometrial invasive bladder cancer do not rule out radical treatment of elderly patients with this disease. However, it is necessary for any kind of treatment to assess its risks and benefits so as to avoid over-treatment, which can not only prolong the survival of patients but also lead to the decline of health-related quality of life. We have muscle invasive bladder cancer older than 70 years